Editorial: International Consensus in Clinical Trial End-Points in Ulcerative Colitis - Clarity or Just a Step in Clearing the Fog?

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.14007
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Editorial: Ulcerative Colitis Submucosal Fibrosis and Inflammation: More Than Just Strictures

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

The METEOR Trial: The Burial of Methotrexate in Ulcerative Colitis?

Gastroenterology
HepatologyGastroenterology
2016English

Clinical Relevance of Circulating Midkine in Ulcerative Colitis

Clinical Chemistry and Laboratory Medicine
BiochemistryMedicineClinical Biochemistry
2009English

POINTS FROM LETTERS: Treatment of Ulcerative Colitis

BMJ
1960English

A Randomised Placebo Controlled Trial of Pegylated Interferon in Active Ulcerative Colitis

Gut
Gastroenterology
2003English

Sulphasalazine in Ulcerative Colitis.

Gut
Gastroenterology
1992English

Clearing the Fog Surrounding Chemobrain

Cell
BiochemistryGeneticsMolecular Biology
2019English

Long-Term Safety of Adalimumab in Clinical Trials in Adult Patients With Crohn's Disease or Ulcerative Colitis

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Ulcerative Colitis in Hematological Malignancies: Paraneoplastic Manifestation or Coincidental Bystander?

Case Reports in Gastrointestinal Medicine
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy